LEVOTHYROXINE 50 MCG TABLET
For 30 tablets
Pharmacies pay
$1.22 filed
30 × $0.04073 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$5.08 filed
30 × $0.16938 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
4.2× estimated
Medicare paid 4.2× what pharmacies pay.
Part D averages every strength and form sold under “Levothyroxine Sodium*” / “Levothyroxine Sodium” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.40 estimated
$1.22 + $0.18 (15%) + $5.00 fee per fill = $6.40
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LEVOTHYROXINE 50 MCG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as levothyroxine sodium.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Lannett Company, Inc and Major Pharmaceuticals.
FDA’s Established Pharmacologic Class for it is l-Thyroxine.
The NADAC file of 2026-10-14 prices it under 25 NDCs (National Drug Codes); the FDA directory lists 23 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.22 for 30 tablets (30 × $0.04073 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 12 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Lupin Pharmaceuticals, Inc. | 3 | $0.04073 per EA filed |
| Macleods Pharmaceuticals Limited | 3 | $0.04073 per EA filed |
| Accord Healthcare Inc. | 2 | $0.04073 per EA filed |
| Alvogen, Inc. | 2 | $0.04073 per EA filed |
| Amneal Pharmaceuticals NY LLC | 2 | $0.04073 per EA filed |
| Camber Pharmaceuticals, Inc. | 2 | $0.04073 per EA filed |
| Lannett Company, Inc | 2 | $0.04073 per EA filed |
| Mylan Pharmaceuticals Inc. | 2 | $0.04073 per EA filed |
| NorthStar RxLLC | 2 | $0.04073 per EA filed |
| American Health Packaging | 1 | $0.04073 per EA filed |
| Major Pharmaceuticals | 1 | $0.04073 per EA filed |
| Mylan Institutional Inc. | 1 | $0.04073 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.04073 per EA filed |
All 25 NDCs, with labeler and price
- 00378-1803-10 · Mylan Pharmaceuticals Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 00378-1803-77 · Mylan Pharmaceuticals Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 00527-3281-43 · Lannett Company, Inc · $0.04073 per EA · eff. 2026-09-23 filed
- 00527-3281-46 · Lannett Company, Inc · $0.04073 per EA · eff. 2026-09-23 filed
- 00904-6950-61 · Major Pharmaceuticals · $0.04073 per EA · eff. 2026-09-23 filed
- 16729-0448-15 · Accord Healthcare Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 16729-0448-17 · Accord Healthcare Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 31722-0285-10 · Camber Pharmaceuticals, Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 31722-0285-90 · Camber Pharmaceuticals, Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 33342-0394-10 · Macleods Pharmaceuticals Limited · $0.04073 per EA · eff. 2026-09-23 filed
- 33342-0394-11 · Macleods Pharmaceuticals Limited · $0.04073 per EA · eff. 2026-09-23 filed
- 33342-0394-44 · Macleods Pharmaceuticals Limited · $0.04073 per EA · eff. 2026-09-23 filed
- 47781-0643-10 · Alvogen, Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 47781-0643-90 · Alvogen, Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 51079-0440-01 · not listed as a package in the FDA directory · $0.04073 per EA · eff. 2026-09-23 filed
- 51079-0440-20 · Mylan Institutional Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 60687-0464-01 · American Health Packaging · $0.04073 per EA · eff. 2026-09-23 filed
- 60687-0464-11 · not listed as a package in the FDA directory · $0.04073 per EA · eff. 2026-09-23 filed
- 68180-0966-01 · Lupin Pharmaceuticals, Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 68180-0966-03 · Lupin Pharmaceuticals, Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 68180-0966-09 · Lupin Pharmaceuticals, Inc. · $0.04073 per EA · eff. 2026-09-23 filed
- 69238-1831-01 · Amneal Pharmaceuticals NY LLC · $0.04073 per EA · eff. 2026-09-23 filed
- 69238-1831-07 · Amneal Pharmaceuticals NY LLC · $0.04073 per EA · eff. 2026-09-23 filed
- 72603-0661-01 · NorthStar RxLLC · $0.04073 per EA · eff. 2026-09-23 filed
- 72603-0661-02 · NorthStar RxLLC · $0.04073 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
46 other products in the NADAC file share the FDA nonproprietary name levothyroxine sodium with LEVOTHYROXINE 50 MCG TABLET. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LEVOTHYROXINE 25 MCG TABLET | $0.03506 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 50 MCG TABLET this page | $0.04073 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 75 MCG TABLET | $0.04612 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 88 MCG TABLET | $0.04947 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 100 MCG TABLET | $0.04972 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 112 MCG TABLET | $0.05879 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 125 MCG TABLET | $0.05704 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 137 MCG TABLET | $0.06388 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 150 MCG TABLET | $0.05858 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 175 MCG TABLET | $0.07347 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 200 MCG TABLET | $0.08099 per EA filed | $0.16938 per EA filed |
| LEVOTHYROXINE 300 MCG TABLET | $0.10428 per EA filed | $0.16938 per EA filed |
| LEVOXYL 25 MCG TABLET | $0.75283 per EA filed | $0.51808 per EA filed |
| LEVOXYL 50 MCG TABLET | $0.85394 per EA filed | $0.51808 per EA filed |
| LEVOXYL 75 MCG TABLET | $0.94482 per EA filed | $0.51808 per EA filed |
| LEVOXYL 100 MCG TABLET | $0.9697 per EA filed | $0.51808 per EA filed |
| LEVOXYL 112 MCG TABLET | $1.11616 per EA filed | $0.51808 per EA filed |
| LEVOXYL 125 MCG TABLET | $1.12965 per EA filed | $0.51808 per EA filed |
| LEVOXYL 137 MCG TABLET | $1.15032 per EA filed | $0.51808 per EA filed |
| LEVOXYL 150 MCG TABLET | $1.16868 per EA filed | $0.51808 per EA filed |
| LEVOXYL 175 MCG TABLET | $1.38792 per EA filed | $0.51808 per EA filed |
| LEVOXYL 200 MCG TABLET | $1.34463 per EA filed | $0.51808 per EA filed |
| SYNTHROID 50 MCG TABLET | $1.66208 per EA filed | $0.9878 per EA filed |
| UNITHROID 50 MCG TABLET | $4.18292 per EA filed | $0.58122 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 25 NDCs’ NADAC prices is $0.04073 per EA filed.
Of the 55 other products in FDA’s l-Thyroxine class priced per EA, 54 have a higher middle NADAC price and 1 a lower one. The one in the middle is LEVOXYL 150 MCG TABLET, at $1.16868 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $5.08 for 30 tablets, at an average of $0.16938 per EA in 2024 (2024-01-01 to 2024-12-31) for “Levothyroxine Sodium*” and “Levothyroxine Sodium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 43,253,940 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for LEVOTHYROXINE 50 MCG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Levothyroxine Sodium* / Levothyroxine Sodium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 299 NADAC NDCs the name join matched to it have an FDA route including ORAL. 21 of the 299 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).